Genelux Corp - GNLX Accounting Value per Share

Official company branding of Genelux Corp (GNLX)

Genelux Corporation (GNLX) develops anti-tumor systems through partnerships with scientific centers, utilizing automated virus incubation modules to eliminate human error. This daily price action reflects the activity of the asset, which has a metric of 0.36. The business focuses on the development of oncolytic agents for solid tumors, awaiting key Phase III trial data and synergy with immunotherapy.

GNLX Genelux Corporation Net Asset Value per Share (04/28/2023 - 10/29/2026)

GNLX (Genelux Corp.): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart Genelux Corp|GNLX - Price Target Chart
- issuer market value details:
Market Valuation Genelux Corporation|GNLX - Business Value
- balance sheet net asset value indicators:
Net Assets per Single Share Genelux|GNLX - Total Stockholders' Equity|Market Value to Book Value Ratio genelux.com|GNLX - Total Business Assets
- debt burden and liquidity indicators:
Total Debt to Capital Genelux Corporation|GNLX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Genelux Corp|GNLX - Company Cumulative Debt|Debt to Book Capitalization Ratio Genelux Corporation|GNLX - Company Long-Term Debt|Company Short-Term Debt Genelux|Quick Ratio genelux.com
- earnings and multiples data:
GNLX - Annual Net Income
Basic company analysis:GNLX - genelux.com
Manufactured products of Genelux Corp

A conservative investor evaluates this metric as the ratio of equity to the number of shares, which allows for the determination of the real value of net assets through a historical assessment of the book value per share. For Genelux Corporation (GNLX), the growth of this indicator confirms capitalization driven by advances from pharma behemoths for the development of Olvi-Vec, creating a solid financial foundation prior to reaching break-even.

Competitor analysis for Genelux Corporation

GERN - Net Assets per Single Share|NBTX: Net Assets per Single Share|BCYC (Bicycle Therapeutics) - Accounting Value per Share|Equity per Share CTMX|Net Assets per Single Share Perspective Tx|Net Asset Value per Share molecularpartners.com MOLN|Net Assets per Single Share Oncolytics Biotech Inc. (ONCY)|lisata.com - Equity per Share|Book Value per Share MBRX (Moleculin Biotech)|GRTX - Accounting Value per Share|MTEM - Net Assets per Single Share